Seonglae ChoFDA approves controversial new drug designed to slow the progress of ALS
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig's disease, a victory for patients and advocates despite limited evidence that the drug is effective.
https://www.nbcnews.com/health/health-news/fda-approves-controversial-new-drug-designed-slow-progression-als-rcna48763
A.L.S. Stole His Voice. A.I. Retrieved It.
In an experiment that surpassed expectations, implants in a patient’s brain were able to recognize words he tried to speak, and A.I. helped produce sounds that came close to matching his true voice.
https://www.nytimes.com/2024/08/14/health/als-ai-brain-implants.html?unlocked_article_code=1.DU4.mn64.bFvgP77BpFAe
